The Role of Microbiota in the Development of Cancer Tumour Cells and Lymphoma of B and T Cells
- PMID: 34853760
- PMCID: PMC8608681
- DOI: 10.7759/cureus.19047
The Role of Microbiota in the Development of Cancer Tumour Cells and Lymphoma of B and T Cells
Abstract
Human body harbours enormous numbers of microbial organisms, including bacteria, viruses, and fungi which have a momentous role in well-being and illness in humans. Immune system shelters us from pathogenic bacteria, microorganisms found in human tissues have many benefits related to the functional movement of the host by regulating important procedures such as immunity, signalling, and breakdown. Lymphocytes assume a significant part in the reaction to bacterial colonization, primarily by prompting a safe reaction to obstruction or initiation. Most immunologically occupant cells have a place with the mucosal invulnerable framework and are continually motioned by dendritic cells or other Antigen introducing cells that gather intestinal samples. Thus, Microbiome is a key contributor to developing lymphoma and specific alterations to microbiome composition could attenuate the risk. There is an indication that microbial morphology can affect and control humanoids. The difference in the composition of these microorganisms is associated with tumour development. With the increased knowledge of the connection among the human microbiome and carcinogenesis, the use of these findings to prevent, predict or diagnose of lymphomas has attracted a great attention. In this article, we explored current knowledge of various microbial ecosystems, their connection with carcinogens and the potential for useful microorganisms to control and prevent B and T cell lymphoma.
Keywords: b and t cell lymphoma; carcinogens; lymphocytes; microbiota; microorganism.
Copyright © 2021, Mamgain et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
The microbiome-systemic diseases connection.Oral Dis. 2016 Nov;22(8):719-734. doi: 10.1111/odi.12472. Epub 2016 Apr 26. Oral Dis. 2016. PMID: 26953630 Review.
-
Gut microbiome and adaptive immunity in schizophrenia.Psychiatriki. 2019 Jul-Sep;30(3):189-192. doi: 10.22365/jpsych.2019.303.189. Psychiatriki. 2019. PMID: 31685450 English, Greek, Modern.
-
Intestinal microbiome and lymphoma development.Cancer J. 2014 May-Jun;20(3):190-4. doi: 10.1097/PPO.0000000000000047. Cancer J. 2014. PMID: 24855006 Free PMC article. Review.
-
The possible mechanisms of the human microbiome in allergic diseases.Eur Arch Otorhinolaryngol. 2017 Feb;274(2):617-626. doi: 10.1007/s00405-016-4058-6. Epub 2016 Apr 26. Eur Arch Otorhinolaryngol. 2017. PMID: 27115907 Review.
-
Microbiome analysis, the immune response and transplantation in the era of next generation sequencing.Hum Immunol. 2021 Nov;82(11):883-901. doi: 10.1016/j.humimm.2021.07.009. Epub 2021 Aug 5. Hum Immunol. 2021. PMID: 34364710
Cited by
-
The Gut Connection: Exploring the Possibility of Implementing Gut Microbial Metabolites in Lymphoma Treatment.Cancers (Basel). 2024 Apr 11;16(8):1464. doi: 10.3390/cancers16081464. Cancers (Basel). 2024. PMID: 38672546 Free PMC article. Review.
-
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review.Int J Mol Sci. 2024 Oct 23;25(21):11384. doi: 10.3390/ijms252111384. Int J Mol Sci. 2024. PMID: 39518937 Free PMC article. Review.
References
-
- Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Topping DL, Clifton PM. Physiol Rev. 2001;81:1031–1064. - PubMed
Publication types
LinkOut - more resources
Full Text Sources